COVID-19 (An International Trauma): A Brief Analysis on Research Trends, Impacts and Solutions

  • Dr. Mahima Sharma
Keywords: COVID-19, Corona Virus, Pneumonia, Immune System, Fatal, Epidemic

Abstract

Corona virus disease (COVID-19); have been established as an epidemic of the century.  COVID-19, a pandemic is spreading its web throughout the world affecting everyone resulting into mass destruction of populations causing human suffering, creating panic, disturbing everyone economically and stressing all kind of development of entire mankind. COVID-19 is a deadly disease that is supposed to be fatal in 4% of cases. In Severe cases this disease produces enormous respiratory harm like pneumonia, gastrointestinal disorders, weakened immune systems, kidney failure or even death. The pathology of COVID-19 is just similar to SARS and Middle Eastern respiratory syndrome (MERS) corona virus infection. There are no drugs or vaccines for corona viruses yet, including COVID-19. According to WHO Corona virus disease (COVID-19) outbreak situation is persisting with 421,792 confirmed cases ‎and 18,883 confirmed deaths till 23‎ ‎March‎ ‎2020‎. Till now, there are no specific vaccines or treatments for COVID-19. Though, there are multiple of clinical trials, evaluations that may result into potential treatments are ongoing.

Downloads

Download data is not yet available.

References

Huang C. Wang Y. Li X, (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet., 395, 497-506

Hui DS. I Azhar E. Madani TA. Ntoumi F. Kock R. Dar O. (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health :The latest 2019 novel coronavirus outbreak in Wuhan, China, Int J Infect Dis, 264–66.

World Health Organization (WHO). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)"2020. 2020.

Centers for Disease Control and Prevention (CDC). (2020). Coronavirus Disease 2019 (COVID-19).

Kahn J. McIntosh K. (2020). History and recent advances in coronavirus discovery. Pediatric Infectious Disease Journal, 24(11), 223–227.

Sexton NR. Smith EC. Blanc H. Vignuzzi M,. Peersen OB. Denison MR. (2020) Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens. Journal of Virology, 90 (16), 7415–7428

Corman VM. Muth D. Niemeyer D. Drosten C. (2018). Hosts and Sources of Endemic Human Coronaviruses. Advances in Virus Research, 100, 163–88.

Li F. Li W. Farzan M. Harrison SC. (2005). Structure of SARS coronavirus spike receptor-binding domain complexed with receptor, Science, 309 (5742), 1864–68.

Doucleef M. (2012) Scientists Go Deep On Genes Of SARS-Like Virus.

World Health Organization (WHO) .2020. Naming the coronavirus disease (COVID-19) and the virus that causes it.

Hui David S. Azhar I. Esam M. Tariq A. Ntoumi F. Kock R. Dar O. Ippolito G. Mchugh T D. Memish Z A. Drosten C Z. Alimuddin P E. (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases, 91, 264–66.

Ding Y .Wang H. Shen H (2003). The clinical pathology of severe acute respiratory syndrome (SARS): China. J Pathol, 200, 282-289

World Health Organization (WHO). (2020). Novel Coronavirus (2019-nCoV) Situation Report – 10.

Coronavirus Update (Live): 935,957 Cases and 47, 245 Deaths from COVID-19 Virus Outbreak - Worldometer.

Doremalen V N. Bushmaker T. Morris DH. Holbrook MG. Gamble A. Williamson BN. (2020). Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1, The New England Journal of Medicine. Massachusetts Medical Society.

Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) – Symptoms.2020.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223), 497–506.

Lai C, Shih T, Ko W, Tang H, Hsueh P. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents, 55 (3), 105.

Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O. (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – The latest 2019 novel coronavirus outbreak in Wuhan, China". Int J Infect Dis. 91, 264–66

World Health Organization (WHO). (2020) Coronavirus disease 2019 (COVID-19): situation report, 29.

Centers for Disease Control. (2020). Coronavirus Disease 2019 (COVID-19): Prevention & Treatment.

Anderson R M. Heesterbeek H. Klinkenberg D. Hollingsworth TD. (2020). How will country-based mitigation measures influence the course of the COVID-19 epidemic?. Lancet, 395 (10228), 931–934.

Grenfell R. Drew T.(2020). Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus. Science Alert.

Jiang S. Lu L D. Lanying. (2013). Development of SARS vaccines and therapeutics is still needed. Future Virology, 8 (1), 1–2.

Helen B. (2020). WHO to launch multinational trial to jumpstart search for coronavirus drugs. STAT.

US Food and Drug Administration. (2020). Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments.

Clinical Trials Arena. (2020). China approves first anti-viral drug against coronavirus Covid-19.

Centre for disease control and prevention. (2020). Corona virus disease 2019 Therapeutic options for patients with covid-19.

Wang M. Cao R. Zhang L. Yang X. Liu J. Xu M. Shi Z. Hu Z. Zhong W. Xiao G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30(3), 269-271.

Colson P. Rolain JM. Lagier JC. Brouqui P. Raoult D. (2020). Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, Int J Antimicrob Agents.

Gautret P. Lagier J. Parola . Hoang V. Meddeb L. Mailhe M. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, International Journal of Antimicrobial Agents.

Cao B. Wang Y. Wen D. Liu W. Wang J. Fan G. Ruan L. Song B. Cai Y. Wei M. Li X. Xia J. Chen N. Xiang J. Yu T. Bai T. Xie X. Zhang L. Li C. Yuan Y. Chen H. Li H. Huang H. Tu S. Gong F. Liu Y. Wei Y. Dong C. Zhou F. Gu X. Xu J. Liu Z. Zhang Y. Li H. Shang L. Wang K. Li K. Zhou X. Dong X. Qu Z. Lu S. Hu X. Ruan S. Luo S. Wu J. Peng L. Cheng F. Pan L. Zou J. Jia C. Wang J. Liu X. Wang S. Wu X. Ge Q. He J. Zhan H. Qiu F. Guo L. Huang C. Jaki T. Hayden FG. Horby PW. Zhang D. Wang C. (2020). A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19, N Engl. J Med.

The Print (2020). HIV drug combo approved by ICMR for coronavirus treatment fails clinical trials in China.

Mohammad Reza Dayer. Sara Taleb-Gassab. Mohammad Saaid Dayer.(2020) Archives of Clinical Infectious Diseases Infectious Diseases and Tropical Medicine Research Center, SBUMS.

COVID-19 Coronavirus Real Time Updates With Credible Sources in US and Canada. coronavirus.

Dipartimento della Protezione Civile. COVID-19 Italia - Monitoraggio della situazione. Avilable at: opendatadpc.maps.arcgis.com.

El mapa del coronavirus en España: 11.947 muertos y más de 126.000 casos". (2020). RTVE.. National Health Commission.

截至4月4日24时新型冠状病毒肺炎疫情最新情况 . (2020). National Health Commission.

Corona-Karte Deutschland. COVID-19 live in allen Landkreisen und Bundesländern. Tagesspiegel. (2020). Coronavirus death toll hits 3,036 in Iran", IRNA English.

Nombre cumulé de personnes retournées à domicile depuis le 1er mars 2020.(2020). geodes. santepubliquefrance.

Cas d'infection au Sars-CoV-2 en Suisse. Tribune de Genève.

Number of coronavirus (COVID-19) cases and risk in the UK". Available at: www.gov.uk

Cas d'infection au Sars-CoV-2 en Suisse. (2019). Tribune de Genève (in French).

Novel Coronavirus (2019-nCoV). (2020). US Centers for Disease Control and Prevention.

Home - Ministry of Health and Family Welfare - GOI". (2020).COVID-19—History and exam". BMJ Best Practice. (2020).

Cheng PW. Ng LT. Chiang LC. Lin CC. (2006). Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin Exp Pharmacol Physiol, 33,612–6.

Li SY. Chen C. Zhang HQ. Guo HY. Wang H. Wang L. (2005). Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir Res, 67,18–23.

Lin CW. Tsai FJ. Tsai CH. Lai CC. Wan L. Ho TY (2005). Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antivir Res, 68, 36–42.

Ryu YB. Jeong HJ. Kim JH. Kim YM. Park JY. Kim D. (2010). Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL (pro) inhibition. Bioorg Med Chem, 18, 7940–7947.

Yu MS. Lee J. Lee JM. Kim Y. Chin YW. Jee JG (2012). Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg Med Chem Lett, 22, 4049–4054

Lau KM. Lee KM. Koon CM. Cheung CS. Lau CP. Ho HM. (2008). Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol, 118, 79–85

What To Do if You Are Sick with COVID-19. (2020). Centers for Disease Control and Prevention.

Van der Hoek L. (2007). Human coronaviruses: What do they cause? Antivir Ther., 12,651–658.

Centers for Disease Control and Prevention. (2020). Coronavirus Disease 2019 (COVID-19).

World Health Organization. (2020). Advice for public.

What to do if you are sick with 2019 Novel Coronavirus (2019-nCoV). (2020). US Centers for Disease Control and Prevention.

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). ArcGIS. Johns Hopkins CSSE.

StatPearls NCBI : Features, Evaluation and Treatment Coronavirus (COVID-19) Marco Cascella; Michael Rajnik; Arturo Cuomo; Scott C. Dulebohn; Raffaela Di Napoli. 2020.

Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY. (2020). Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect, 9(1), 221-236.

Fehr AR, Perlman S (2015). Maier HJ, Bickerton E, Britton P (Eds.). Coronaviruses: an overview of their replication and pathogenesis. Methods in Molecular Biology. Springer. 1282: 1–23.

Perlman S, Netland J. (2009). Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol., 7(6), 439-450.

Lei J, Kusov Y, Hilgenfeld R. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. Antiviral Res. 2018; 149:58-74.

Song W, Gui M, Wang X, Xiang Y. (2018). Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog., 14(8).

Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M. COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis. J. Med. Virol. 2020.

Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. (2020). pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) Pneumonia in two patients with lung cancer. J Thorac Oncol..

Gordon CJ, Tchesnokov EP, Feng JY, Porter DP, Gotte M. (2020). The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J. Biol. Chem.

Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, Scott D, Cihlar T, Feldmann H. (2020). Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc. Natl. Acad. Sci. U.S.A.

Wu Z, McGoogan JM. (2020). Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA..

Kogan A, Segel MJ, Ram E, Raanani E, Peled-Potashnik Y, Levin S, Sternik L. (2019). Acute respiratory distress syndrome following cardiac surgery: comparison of the american-european consensus conference definition versus the berlin definition. Respiration, 97(6), 518-524.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. (2016). The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA, 315(8), 801-810.

Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, Berry S, Clermont G, Cooper G, Gomez H, Huang DT, Kellum JA, Mi Q, Opal SM, Talisa V, van der Poll T, Visweswaran S, Vodovotz Y, Weiss JC, Yealy DM, Yende S, Angus DC. (2019). Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA, 321(20), 2003-2017.

Matics TJ, Sanchez-Pinto LN. (2017). Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the sepsis-3 definitions in critically ill children. JAMA Pediatr, 171(10).

Turkey's coronavirus death toll rises to 501, with 23,934 total cases. (2020). Hürriyet Daily News.

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). (2020). ArcGIS. Johns Hopkins CSSE.

Horowitz, Jason. (2020). Italy Announces Restrictions Over Entire Country in Attempt to Halt Coronavirus. The New York Times. (ISSN 0362-4331).

Juliana Kaplan, Lauren Frias and Morgan McFall-Johnsen. (2020). A third of the global population is on coronavirus lockdown — here's our constantly updated list of countries and restrictions. Business Insider.

Rupa Subramanya. (2020). Covid-19 total lockdown: An economic and humanitarian disaster. India Matters.

World Health Organisation. (2020 30 Feb). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). The Lancet.

Published
2020-04-10
How to Cite
Dr. Mahima Sharma. (2020). COVID-19 (An International Trauma): A Brief Analysis on Research Trends, Impacts and Solutions. International Journal for Research in Applied Sciences and Biotechnology, 7(2), 1-8. https://doi.org/10.31033/ijrasb.7.2.1
Section
Articles